Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

[1]  N. Palanisamy,et al.  Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer , 2011, Clinical Cancer Research.

[2]  A. Poustka,et al.  Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodules. , 2009, The Journal of thoracic and cardiovascular surgery.

[3]  J. Minna,et al.  Focus on lung cancer. , 2002, Cancer cell.

[4]  Gideon Rechavi,et al.  Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Lynch,et al.  The National Lung Screening Trial: overview and study design. , 2011, Radiology.

[6]  P Barbry,et al.  miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity , 2011, Cell Death and Differentiation.

[7]  V. Ambros.  MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[8]  M. Pepe.  The Statistical Evaluation of Medical Tests for Classification and Prediction , 2003 .

[9]  Robert A Smith,et al.  Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects , 2007, CA: a cancer journal for clinicians.

[10]  Millennia Foy,et al.  Assessment of lung-cancer mortality reduction from CT Screening. , 2011, Lung cancer.

[11]  Armin Ernst,et al.  State of the art: interventional pulmonology. , 2007, Chest.

[12]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[13]  A. Palmieri,et al.  MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression , 2010, International journal of immunopathology and pharmacology.

[14]  A. Harris,et al.  Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.

[15]  F. Jiang,et al.  Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers , 2010, Modern Pathology.

[16]  Norbert Senninger,et al.  Involvement of CD40 Targeting miR-224 and miR-486 on the Progression of Pancreatic Ductal Adenocarcinomas , 2009, Annals of Surgical Oncology.

[17]  S. Knudsen,et al.  Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. , 2010, Cancer research.

[18]  Shuomin Zhu,et al.  MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.

[19]  Feng Jiang,et al.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers , 2010, International journal of cancer.

[20]  Xi Chen,et al.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Hong Peng,et al.  Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. , 2010, Lung cancer.

[22]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[23]  A. Gazdar,et al.  Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[25]  W. Rom,et al.  Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR , 2010, Clinical Cancer Research.

[26]  S. Belinsky,et al.  DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer. , 2008, Nutrition reviews.

[27]  M. L. R. D. Christenson,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[28]  K. Kosik,et al.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.

[29]  Ricky T. Tong,et al.  Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. , 2009, Molecular cell.

[30]  S. Volinia,et al.  Non-coding RNAs: a key to future personalized molecular therapy? , 2010, Genome Medicine.

[31]  Zhenqiu Liu,et al.  Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. , 2009, Lung cancer.

[32]  Feng Jiang,et al.  Plasma microRNAs as potential biomarkers for non-small-cell lung cancer , 2010, Laboratory Investigation.

[33]  Martial Guillaud,et al.  Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: Correlation with genetic damage and cancer development , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[34]  L. Buscail,et al.  MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. , 2010, Clinical chemistry.

[35]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[36]  D. Ost,et al.  Clinical practice. The solitary pulmonary nodule. , 2003, The New England journal of medicine.

[37]  Richard Simon,et al.  Gene expression-based prognostic signatures in lung cancer: ready for clinical use? , 2010, Journal of the National Cancer Institute.

[38]  S. Belinsky,et al.  Gene-promoter hypermethylation as a biomarker in lung cancer , 2004, Nature Reviews Cancer.

[39]  Ann M. Killary,et al.  MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease , 2009, Cancer Prevention Research.

[40]  Ugo Pastorino,et al.  MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer , 2011, Proceedings of the National Academy of Sciences.

[41]  X. Yao,et al.  Serum miRNA‐21: Elevated levels in patients with metastatic hormone‐refractory prostate cancer and potential predictive factor for the efficacy of docetaxel‐based chemotherapy , 2011, The Prostate.

[42]  M. Neri,et al.  miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  D. Ost,et al.  Solitary Pulmonary Nodule , 2005 .

[44]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[45]  A. Schwartz,et al.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[46]  P. Platzer,et al.  Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. , 2008, American journal of human genetics.

[47]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[48]  N. Miller,et al.  Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer , 2008, BMC Molecular Biology.

[49]  W. C. Ball,et al.  Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. , 2015, The American review of respiratory disease.

[50]  A. Rastogi,et al.  Feasibility of MicroRNAs as Biomarkers for Barrett's Esophagus Progression: A Pilot Cross-Sectional, Phase 2 Biomarker Study , 2011, The American Journal of Gastroenterology.

[51]  John W M Martens,et al.  Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer , 2008, Proceedings of the National Academy of Sciences.

[52]  Holly Janes,et al.  Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design , 2008, Journal of the National Cancer Institute.

[53]  Catherine Beigelman-Aubry,et al.  Management of an incidentally discovered pulmonary nodule , 2007, European Radiology.

[54]  K. Pantel,et al.  Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer , 2011, Molecular oncology.